Almirall S.A. is a global pharmaceutical company focused on medical dermatology, developing treatments for skin conditions such as psoriasis, atopic dermatitis, and actinic keratosis. Founded in 1944, the company serves patients and healthcare professionals with a portfolio that includes biological therapies, small molecules, and topical treatments. Key products include fumaric acid ester treatments for psoriasis and biologics for moderate-to-severe atopic dermatitis. The company maintains a dedicated R&D center in Barcelona and has expanded its presence through acquisitions of Hermal, Aqua Pharmaceuticals, and Poli Group. Almirall collaborates with partners including Simcere, Absci, and the Barcelona Supercomputing Center to advance skin science and develop new therapeutic solutions.

Summarised from the company's own disclosures, fiscal year ended Dec 2025

Industry Drug Manufacturers - General Homepage almirall.com
Sector Healthcare IR page almirall.com
Tags
medical dermatology, psoriasis, atopic dermatitis, actinic keratosis, biologics, topical treatments, small molecules, skin conditions, r&d, pharmaceuticals, Hermal, Aqua Pharmaceuticals, Poli Group, Simcere, Absci, Barcelona Supercomputing Center, Athenex, Allergan, Dermira, Prodesfarma
Press page —

Metrics

Valuation  
Market cap € 1.695B
Market cap (USD) $ 1.901B
P/E 28.86
PEG 0.24
P/BV 1.11
P/S 1.47
P/OCF 6.82
P/FCF 12.15
Dividend yield 2.4%
Turnover / mcap —
Returns  
ROE 3.1%
ROI 3.9%
ROIC 3.8%
Profit margin 4.2%
Growth  
Revenue growing Yes
Profits growing Yes
Revenue up 3y Yes
Revenue up 5y Yes
Earnings growth 3y (net profit CAGR) 120.9%
Quality  
Profitable Yes
Margin expanding Yes
Buying back stock No
Diluting (TTM) —
Debt/Equity —
Podcast bulls (TTM) Sign up
Podcast bears (TTM) Sign up
Podcast sentiment (TTM) Sign up
Podcast sentiment % (TTM) Sign up
News sentiment (TTM) 6
Quality score 16.7%
Insiders  
Buys, 1w Sign up
Buys, 1m Sign up
Buys, 1y Sign up
Sells, 1w Sign up
Sells, 1m Sign up
Sells, 1y Sign up

Sign up to see this company's insider trades

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Revenue 1.108B 985.721M 894.516M 863.248M 827.195M 807.427M 855.339M 756.934M 639.381M 764.361M 684.985M 786.396M 692.891M 682.882M 768.418M 882.438M
Net profit 46.154M 10.147M 38.474M 4.281M 40.859M 74.28M 105.909M 77.674M -303.961M 75.479M 131.826M 448.429M -33.717M 76.291M 84.166M 118.604M
Free cash flow 139.549M 130.932M 59.986M 132.095M 215.038M 100.866M — — — — — — — — — —

Figure FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016 FY 2015 FY 2014 FY 2013 FY 2012 FY 2011 FY 2010
Share price — — 8.08 — 10.8 10.8 11.16 — — — — — — — — —
Price performance 12m — — — — 0 -0.03 — — — — — — — — — —

Filed figures

Figure Dec 2019 Dec 2020 Dec 2021 Dec 2022 Dec 2023 Dec 2024 Dec 2025
Balance sheet detail
Trade receivables (EUR) — 111M 128M 138M 131M 151M 158M
↳ YoY growth +14.7% +8.3% -4.9% +15.2% +4.6%
↳ 5y CAGR +7.3%
Lease liabilities (EUR) — 19.7M 20.4M 39M 43.8M 44.6M 42.3M
Cash and deposits (EUR) 117M 166M 207M 249M 388M 377M 338M
Intangible assets (EUR) — 1.01B 916M 899M 951M 937M 894M
Right-of-use assets (EUR) — 19.3M 20M 38.7M 43M 43.6M 40.8M
Cash flow detail
Operating cash flow (EUR) — 113M 234M 155M 93.5M 161M 174M
Purchases of property, plant and equipment (EUR) — -11.9M -18.8M -23M -33.5M -29.8M -34.9M
Purchases of intangible assets (EUR) — -64.6M -52.3M -93.5M -126M -132M -102M
Change in receivables (cash effect) (EUR) — -106M 13.1M -2.88M -3.15M -4.72M -26.1M
Change in inventories (cash effect) (EUR) — 25.3M -13.3M 10.7M -37.1M -3.53M -7.65M
Change in payables (cash effect) (EUR) — 57.5M -11M -6.27M -9.39M 1.05M 9.38M
Dividends paid (cash effect) (EUR) — -2.13M -11.7M -12.4M -2.59M -3.29M -26.2M
Share buybacks (cash effect) (EUR) — -82,000 -596,000 -46,000 -157,000 -539,000 -1.31M
Interest paid (cash effect) (EUR) — -6.54M -6.13M -9.9M -10.2M -10.5M -11.5M
Income taxes paid (cash effect) (EUR) — -26.3M 23.5M -6.36M 13.6M 24.2M 35.6M
Operating cash flow before change in receivables (EUR) — 219M 221M 158M 96.6M 165M 201M
Free cash flow (OCF - PPE - intangibles) (EUR) — 36.2M 163M 38.6M -65.8M -664,000 37.2M
Income detail
Total comprehensive income (EUR) — 25.4M 5.31M 45.5M 50.7M 27.1M 21.6M
Comprehensive income to owners (EUR) — 25.4M 5.31M 45.5M -50.7M 27.1M 21.6M
Reported Feb 21, 2022 Feb 21, 2022 Feb 21, 2022 Feb 20, 2023 Feb 19, 2024 Feb 24, 2025 Feb 23, 2026

Sign up to see institutional holdings

Sign Up

Podcast Mentions

Sign up to see podcast mentions and sentiment

Sign Up

World Psoriasis Day: The Deeper Truth Bull 0 Bear 0 Routine

Dermatology

Go to Dermatology

Deeper Truth

Published on October 29, 2026

Today, on World Psoriasis Day, we’re looking beyond the visible and raising awareness of the impact psoriasis can have beyond the skin.

In a digital world increasingly shaped by filters and edited images, the realities of living with a visible skin condition can easily go unseen. Psoriasis is visible on the skin, but its psychological burden may be much less apparent and can be an important part of the experienceof people living with the disease.

In collaboration with IFPA, we’re helping bring greater visibility to this often less visible side of psoriasis, encouraging a deeper understanding of the experiences behind the symptoms and the impact the condition can have on people’s lives.

World Psoriasis Day is also an opportunity to listen, learn and continue building awareness around the realities faced by people living with psoriasis.

Because understanding psoriasis meanslooking beyond what we can see.

Almirall

Privacy Preference Center

When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences, or your device, and is mostly used to make the site work as you expect. The information does not usually identify you directly, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to learn more and change our default settings. Blocking some types of cookies may impact your experience of the site and the services we are able to offer.

Allow All

Manage Consent Preferences

Marketing Cookies

Marketing Cookies Inactive

These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.

Performance Cookies

Performance Cookies Inactive

These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.

Strictly Necessary Cookies

These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.

Functional Cookies

Functional Cookies Inactive

These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.

Cookie List

Clear

  • checkbox label label

Apply Cancel

Leg.Interest

checkbox label label

checkbox label label

checkbox label label

Reject All

Powered by Onetrust

Prompts

ALMIRALL S.A. (ticker ALM), listed in Spain.

ETFs Holding ALMIRALL S.A.

ETF Weight in ETF Shares Market value As of
DISV 0.07% 317,779 $ 3.791M Nov 12, 2026
AVDS 0.03% 10,794 $ 125.757K Nov 16, 2026
DFIS 0.03% 129,956 $ 1.55M Nov 12, 2026
DXIV 0.02% 3,473 $ 41.432K Nov 12, 2026
DFIC 0.01% 96,545 $ 1.152M Nov 12, 2026
DFSI 0.01% 6,423 $ 76.624K Nov 12, 2026
DFAI 0.01% 85,970 $ 1.026M Nov 12, 2026
DFAX 0.00% 38,216 $ 455.904K Nov 12, 2026
AVDE 0.00% 15,281 $ 178.034K Nov 16, 2026
AVSD 0.00% 958 $ 11.161K Nov 16, 2026